Release date: July 10, 2025
Expiration date: July 9, 2027
Estimated Time of Completion: 45 minutes
Session Agenda
Glucocorticoid use in small vessel vasculitis
Benjamin Terrier, MD, PhD
Glucocorticoid use in large vessel vasculitis
Tanaz Kermani, MD
Description
Watch Vasculitis 2025: Advances and Controversies on-demand webcast series, recorded from the Vasculitis 2025: Advances and Controversies course. The focus of the education is to review complexities and innovations in the treatment and diagnosis of various forms of vasculitis.
Learning Objectives
- Evaluate current and future landscape of glucocorticoid use in vasculitis management.
- Review the evidence for glucocorticoid use in giant cell arteritis and Takayasu's arteritis.
- Discuss glucocorticoid taper and duration of glucocorticoid therapy in Giant cell arteritis and Takayasu's arteritis.
Target Audience
The online series is directed towards rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, nurse practitioners, nurses, and physician assistants interested in the treatment of vasculitis.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 0.75 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Rula Hajj-Ali, MD
Associate Director, Center for Vasculitis Care and Research
Vice Chair, Medical Specialty Institute
Department of Rheumatic & Immunologic Diseases
Medical Specialty Institute
Cleveland Clinic
Cleveland, OH
Additional Planners
Debra Kangisser, PA-C
Elizabeth (Betsy) Kirchner, DNP
Faculty
Tanaz Kermani, MD
Founder and Director, Vasculitis Program
Santa Monica Rheumatology
UCLA Health
Santa Monica, CA
Benjamin Terrier, MD, PhD
Université Paris Cité
Paris, France
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Faculty Disclosure
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated they have no relationship which, in the context of his/her presentation(s), could be perceived as a potential conflict of interest
| Rula Hajj-Ali, MD |
| Amgen |
Advisor or review panel participant |
| GSK |
Advisor or review panel participant (Ended: 12/01/2022) |
| UpToDate, Inc. |
Intellectual property rights (Royalties or patent sales) |
| Elizabeth Kirchner, DNP |
| Lilly |
Consulting (Ended: 06/29/2023) |
Pfizer
Janssen Pharmaceuticals, Inc. |
Consulting |
| RhAPP |
Teaching and Speaking |
All other individuals have indicated no relationship which, in the context of their involvement, could be perceived as a potential conflict of interest.
Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges educational grants for partial support of this activity from:
AstraZeneca Pharmaceuticals
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Rheumatic & Immunologic Diseases,and Cleveland Clinic’s RJ Fasenmyer Center for Clinical Immunology.
